Crinetics Pharmaceuticals, Inc.
CRNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $3 | $3 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4 | $3 | $3 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -86.1% | 185.6% | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -63,161.5% | 100% | 100% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -90,265% | -12,430% | -30,603.9% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -90,972.7% | -11,216% | -26,807.2% | – |
| EPS Diluted | -1.38 | -1.23 | -1.04 | -0.88 |
| % Growth | -12.2% | -18.3% | -18.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |